↓ Skip to main content

Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, September 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy
1 policy source
twitter
16 X users
facebook
1 Facebook page

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol
Published in
Allergy, Asthma & Clinical Immunology, September 2013
DOI 10.1186/1710-1492-9-35
Pubmed ID
Authors

Giovanni A Zurzolo, Katrina J Allen, Steve L Taylor, Wayne G Shreffler, Joseph L Baumert, Mimi L K Tang, Lyle C Gurrin, Michael L Mathai, Julie A Nordlee, Audrey DunnGalvin, Jonathan O’B Hourihane

Abstract

The eliciting dose (ED) for a peanut allergic reaction in 5% of the peanut allergic population, the ED05, is 1.5 mg of peanut protein. This ED05 was derived from oral food challenges (OFC) that use graded, incremental doses administered at fixed time intervals. Individual patients' threshold doses were used to generate population dose-distribution curves using probability distributions from which the ED05 was then determined. It is important to clinically validate that this dose is predictive of the allergenic response in a further unselected group of peanut-allergic individuals.

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 68 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 17%
Researcher 12 17%
Other 7 10%
Student > Master 7 10%
Student > Bachelor 4 6%
Other 12 17%
Unknown 15 22%
Readers by discipline Count As %
Medicine and Dentistry 19 28%
Agricultural and Biological Sciences 13 19%
Chemistry 5 7%
Nursing and Health Professions 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 9 13%
Unknown 16 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2017.
All research outputs
#2,791,130
of 25,374,647 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#166
of 924 outputs
Outputs of similar age
#23,952
of 210,955 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#2
of 10 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 924 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.8. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,955 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.